The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable buzz within the sector. A shift away from Schedule I status, often regarded as outdated and hindering https://indexedbookmarks.com/story20661181/pot-rescheduling-a-expansion-catalyst